Pulmonary Embolism Acute Clinical Trials

13 recruitingLast updated: May 13, 2026

There are 13 actively recruiting pulmonary embolism acute clinical trials across 12 countries. Studies span Not Applicable. Top locations include San Antonio, Texas, United States, Saint Cloud, Minnesota, United States, Bautzen, Germany. Updated daily from ClinicalTrials.gov.


Pulmonary Embolism Acute Trials at a Glance

13 actively recruiting trials for pulmonary embolism acute are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in San Antonio, Saint Cloud, and Bautzen. Lead sponsors running pulmonary embolism acute studies include Akura Medical, Azienda ULSS 8 Berica, and Angiodynamics, Inc..

Browse pulmonary embolism acute trials by phase

Treatments under study

About Pulmonary Embolism Acute Clinical Trials

Looking for clinical trials for Pulmonary Embolism Acute? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pulmonary Embolism Acute trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pulmonary Embolism Acute clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness

Pulmonary Embolism Acute
Angiodynamics, Inc.39 enrolled6 locationsNCT07280247
Recruiting

Repeated Examinations for Typing Pulmonary Embolism

Pulmonary Embolism (PE)Pulmonary Embolism (Diagnosis)Pulmonary Embolism Acute+2 more
Sahlgrenska University Hospital400 enrolled3 locationsNCT07491094
Recruiting
Not Applicable

Early Catheter-directed Treatment of High Risk Pulmonary Embolism

Pulmonary Embolism Acute Massive
Leipzig Heart Science gGmbH210 enrolled18 locationsNCT06672081
Recruiting

Optimal Time for Reperfusion in Acute Pulmonary Embolism

Pulmonary Embolism (Diagnosis)Pulmonary Embolism Acute
Azienda ULSS 8 Berica500 enrolled7 locationsNCT07436702
Recruiting
Not Applicable

Interest of the Chair Lift Test in the Prognostic Evaluation of Pulmonary Embolism: a Single-center Open Prospective Study

Pulmonary EmbolismPulmonary Embolism AcuteNon-severe Pulmonary Embolism+5 more
University Hospital, Rouen180 enrolled1 locationNCT06166329
Recruiting
Not Applicable

Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)

Pulmonary Embolism Acute
Akura Medical118 enrolled12 locationsNCT06672510
Recruiting

Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism

Pulmonary Embolism Acute Massive
Supergene, LLC20,000 enrolled1 locationNCT07245927
Recruiting
Not Applicable

Safety and Effectiveness of the ATC System in the Treatment of Acute PE

Pulmonary Embolism Acute
Akura Medical30 enrolled4 locationsNCT06152341
Recruiting
Not Applicable

Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism

Pulmonary Embolism Acute
Akura Medical15 enrolled1 locationNCT06362928
Recruiting

Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong

Pulmonary Embolism AcutePulmonary Embolism Acute MassivePulmonary Embolism Subacute Massive
Chinese University of Hong Kong1,000 enrolled1 locationNCT07029841
Recruiting

Registry of Catheter Intervention in Pulmonary Embolism

Pulmonary EmbolismPulmonary ThromboembolismsPulmonary Embolism and Thrombosis+2 more
Hospital San Carlos, Madrid300 enrolled1 locationNCT06348459
Recruiting
Not Applicable

'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL

Pulmonary Embolism Acute
Leiden University Medical Center111 enrolled1 locationNCT06833827
Recruiting
Not Applicable

Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients

Pulmonary Embolism Acute
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health100 enrolled1 locationNCT06487052